06 Dec Cambridge

Design of manufacturing facilities for the production of novel therapeutics requires careful planning and consideration of a myriad of factors, such as throughput, biosafety level, product segregation and contamination control, regulatory environment, time to market, and tech transfer challenges. It is a complex mix of elements and requires a project team that can move quickly and effectively to de-risk the investment and meet market demand. Recently, many firms have embarked on ambitious program to bring manufacturing capacity for gene and cell therapies online to meet demand for novel therapeutics.

To arrange a meeting with us, please fill out this form:

GDPR personal data tickbox needed. (Tick here to indicate you have read and understand our Privacy Policy, where it states how we treat your personal data)

Send

Organiser:

Jim Grunwald

Vice President Strategic Development Jim.Grunwald@dpsgroupglobal.com